MX2017007510A - A process for the manufacture of idalopirdine. - Google Patents

A process for the manufacture of idalopirdine.

Info

Publication number
MX2017007510A
MX2017007510A MX2017007510A MX2017007510A MX2017007510A MX 2017007510 A MX2017007510 A MX 2017007510A MX 2017007510 A MX2017007510 A MX 2017007510A MX 2017007510 A MX2017007510 A MX 2017007510A MX 2017007510 A MX2017007510 A MX 2017007510A
Authority
MX
Mexico
Prior art keywords
idalopirdine
manufacture
preparation
disclosed
pharmaceutically acceptable
Prior art date
Application number
MX2017007510A
Other languages
Spanish (es)
Inventor
Nielsen Ole
Fog Jacobsen Mikkel
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Priority claimed from PCT/EP2015/079209 external-priority patent/WO2016091997A1/en
Publication of MX2017007510A publication Critical patent/MX2017007510A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Disclosed herein is a process for the preparation of idalopirdine and pharmaceutically acceptable salts thereof.
MX2017007510A 2014-12-12 2015-12-10 A process for the manufacture of idalopirdine. MX2017007510A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201400721 2014-12-12
PCT/EP2015/079209 WO2016091997A1 (en) 2014-12-12 2015-12-10 A process for the manufacture of idalopirdine

Publications (1)

Publication Number Publication Date
MX2017007510A true MX2017007510A (en) 2017-08-22

Family

ID=59011415

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007510A MX2017007510A (en) 2014-12-12 2015-12-10 A process for the manufacture of idalopirdine.

Country Status (13)

Country Link
EP (1) EP3230265A1 (en)
JP (1) JP2017537128A (en)
KR (1) KR20170093821A (en)
CN (1) CN107001266A (en)
AU (1) AU2015359347A1 (en)
BR (1) BR112017012021A2 (en)
CA (1) CA2968770A1 (en)
CL (1) CL2017001466A1 (en)
CO (1) CO2017005357A2 (en)
IL (1) IL252471A0 (en)
MA (1) MA41148A (en)
MX (1) MX2017007510A (en)
RU (1) RU2017120216A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015362394C1 (en) 2014-12-12 2021-01-28 Japan Tobacco Inc. Dihydropyrimidine-2-one compounds and medicinal uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042685A (en) * 1962-07-03 Process of making g-fluoro tryptamine
AR065804A1 (en) * 2007-03-23 2009-07-01 Smithkline Beecham Corp COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
TW201139370A (en) * 2009-12-23 2011-11-16 Lundbeck & Co As H Processes for the manufacture of a pharmaceutically active agent

Also Published As

Publication number Publication date
KR20170093821A (en) 2017-08-16
CL2017001466A1 (en) 2018-01-05
JP2017537128A (en) 2017-12-14
CA2968770A1 (en) 2016-06-16
RU2017120216A (en) 2019-01-15
CO2017005357A2 (en) 2017-09-20
IL252471A0 (en) 2017-07-31
EP3230265A1 (en) 2017-10-18
AU2015359347A1 (en) 2017-06-08
CN107001266A (en) 2017-08-01
BR112017012021A2 (en) 2018-03-13
MA41148A (en) 2017-10-17

Similar Documents

Publication Publication Date Title
IN2014CH00247A (en)
MX2022016566A (en) Compositions comprising a casein and methods of producing the same.
TW201613872A (en) IRAK4 inhibiting agents
WO2016079751A3 (en) A process for preparation of vortioxetine and polymorphs thereof
MX2017003131A (en) Method for the preparation of 2-alkoxy cyclohexanol.
EP3297678A4 (en) An improved processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
WO2014125506A3 (en) A process for the preparation of ivacaftor and its intermediates
HUP1500584A2 (en) Novel process for the preparation of carboprost tromethamine
PL3218351T3 (en) A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377
IN2013MU00646A (en)
EP3237424A4 (en) Process of making cenicriviroc and related analogs
MA40313A (en) Oral pharmaceutical composition of isotretinoin
EP3099304A4 (en) Novel therapeutics for the treatment of glaucoma
MA40312A (en) Oral pharmaceutical composition of isotretinoin
SG11201704523WA (en) A process for the manufacture of idalopirdine
EP3092217A4 (en) A novel process for preparation of indacaterol or its pharmaceutically acceptable salts
IN2013MU01111A (en)
ZA201606653B (en) Solid forms of a pharmaceutically active compound
EP3174878A4 (en) A process for the preparation of palbociclib
MX2017007510A (en) A process for the manufacture of idalopirdine.
ZA201607265B (en) A process for preparation of levothyroxine and salts thereof
EP3359716A4 (en) A process for the manufacture of a shaped body
MX2016016398A (en) Preparation of piperidine-4-carbothioamide.
IN2014CH01391A (en)
SG11201703330YA (en) Iminosugars useful for the treatment of viral diseases